Disulfidptosis classification of hepatocellular carcinoma reveals correlation with clinical prognosis and immune profile.

Wang, Tianbing; Guo, Kai; Zhang, Di; Wang, Haibo; Yin, Jimin; Cui, Haodong; Wu, Wenyong

Wang, Tianbing; Guo, Kai; Zhang, Di; Wang, Haibo; Yin, Jimin; Cui, Haodong; Wu, Wenyong.

Afiliação

Wang T; Department of General Surgery, Anhui No.2 Provincial People's Hospital, Hefei 230000, China
Guo K; Anhui Medical University, Hefei 230000, China
Zhang D; Anhui No.2 Provincial People's Hospital affiliated to Anhui Medical University, Hefei 230000, China
Wang H; The Fifth Clinical Medical College of Anhui Medical University, Hefei 230000, China
Yin J; Department of General Surgery, Anhui No.2 Provincial People's Hospital, Hefei 230000, China
Cui H; Anhui Medical University, Hefei 230000, China
Wu W; Anhui No.2 Provincial People's Hospital affiliated to Anhui Medical University, Hefei 230000, China

Int Immunopharmacol ; 120: 110368, 2023 07.

Article em En | MEDLINE | ID: mdl-37247499

Assuntos

Carcinoma Hepatocelular; Neoplasias Hepáticas; Humanos; Carcinoma Hepatocelular/diagnóstico; Carcinoma Hepatocelular/genética; Neoplasias Hepáticas/genética; Prognóstico; Imunoterapia; Morte Celular; Microambiente Tumoral; Biomarcadores Tumorais

Palavras-chave

Disulfidptosis; Drug sensitivity; Hepatocellular carcinoma; Immune cell infiltration; Immunotherapy response; Prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Int Immunopharmacol Assunto da revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google